Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia
Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using gen...
Gespeichert in:
Veröffentlicht in: | European journal of pharmacology 2022-09, Vol.931, p.175207-175207, Article 175207 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 175207 |
---|---|
container_issue | |
container_start_page | 175207 |
container_title | European journal of pharmacology |
container_volume | 931 |
creator | Takase, Saeko Liao, Jingzhu Liu, Yue Tanaka, Rinako Miyagawa, Yasuhiro Sawahata, Masahito Sobue, Akira Mizoguchi, Hiroyuki Nagai, Taku Kaibuchi, Kozo Ozaki, Norio Yamada, Kiyofumi |
description | Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using genome-wide analysis. ARHGAP10 encodes a RhoGAP superfamily member that is involved in small GTPase signaling. In mice, Arhgap10 gene variations result in RhoA/Rho-kinase pathway activation. We evaluated the pharmacokinetics of fasudil and hydroxyfasudil using liquid chromatography-tandem mass spectrometry in mice. The antipsychotic effects of fasudil on hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits were also investigated in a MK-801-treated pharmacological mouse schizophrenia model. Fasudil and its major metabolite, hydroxyfasudil, were detected in the brain at concentrations above their respective Ki values for Rho-kinase after intraperitoneal injection of 10 mg kg−1 fasudil. Fasudil improved the hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits in MK-801-treated mice in a dose-dependent manner. Following oral administration of fasudil, brain hydroxyfasudil was detected at concentration above the Ki value for Rho-kinase whilst fasudil was undetectable. MK-801-induced hyperlocomotion was also improved by oral fasudil administration. These results suggest that fasudil has antipsychotic-like effects on the MK-801-treated pharmacological mouse schizophrenia model. There are two isoforms in Rho-kinase, and further investigation is needed to clarify the isoforms involved in the antipsychotic-like effects of fasudil in the MK-801-treated mouse schizophrenia model.
[Display omitted]
•Fasudil and hydroxyfasudil concentrations reached Ki values for Rho-kinase with fasudil (10 mg kg−1, i.p.).•Fasudil improved MK-801-induced deficits in locomotion, social behavior, prepulse inhibition and novel object recognition.•Fasudil may have antipsychotic-like effects comparable to haloperidol and clozapine in schizophrenia. |
doi_str_mv | 10.1016/j.ejphar.2022.175207 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2704869084</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001429992200468X</els_id><sourcerecordid>2704869084</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-626ef95dbe3d989b32cfbf49284b6a481d1eee1c85c3d44c2e708bfa194086503</originalsourceid><addsrcrecordid>eNp9kM1LxDAQxYMouH78Bx569GDXSTZtk4sg4hcIgug5pOnEztptatIV9K-3Sz17moF57w3vx9gZhyUHXl6ul7geWhuXAoRY8qoQUO2xBVeVzqHiYp8tALjMhdb6kB2ltAaAQotiwcJ1P9KQvl0bRnJ5Rx-YoffoxpQFn3mbtg11F5nNXtqQf1BvE2bUt1TTGOLFtE6n3e-NdaEL7-Qy29PGdtkmNNjtMpJr6ScMbcSe7Ak78LZLePo3j9nb3e3rzUP-9Hz_eHP9lDsJxZiXokSvi6bGVaOVrlfC-dpLLZSsSysVbzgicqcKt2qkdAIrULW3XEtQZQGrY3Y-5w4xfG4xjWZDyWHX2R7DNhlRgVSlBiUnqZylLoaUInozxKlB_DYczI6vWZuZr9nxNTPfyXY123Cq8UUYTXKEvcOG4oTPNIH-D_gFviaG8A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2704869084</pqid></control><display><type>article</type><title>Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia</title><source>Access via ScienceDirect (Elsevier)</source><creator>Takase, Saeko ; Liao, Jingzhu ; Liu, Yue ; Tanaka, Rinako ; Miyagawa, Yasuhiro ; Sawahata, Masahito ; Sobue, Akira ; Mizoguchi, Hiroyuki ; Nagai, Taku ; Kaibuchi, Kozo ; Ozaki, Norio ; Yamada, Kiyofumi</creator><creatorcontrib>Takase, Saeko ; Liao, Jingzhu ; Liu, Yue ; Tanaka, Rinako ; Miyagawa, Yasuhiro ; Sawahata, Masahito ; Sobue, Akira ; Mizoguchi, Hiroyuki ; Nagai, Taku ; Kaibuchi, Kozo ; Ozaki, Norio ; Yamada, Kiyofumi</creatorcontrib><description>Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using genome-wide analysis. ARHGAP10 encodes a RhoGAP superfamily member that is involved in small GTPase signaling. In mice, Arhgap10 gene variations result in RhoA/Rho-kinase pathway activation. We evaluated the pharmacokinetics of fasudil and hydroxyfasudil using liquid chromatography-tandem mass spectrometry in mice. The antipsychotic effects of fasudil on hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits were also investigated in a MK-801-treated pharmacological mouse schizophrenia model. Fasudil and its major metabolite, hydroxyfasudil, were detected in the brain at concentrations above their respective Ki values for Rho-kinase after intraperitoneal injection of 10 mg kg−1 fasudil. Fasudil improved the hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits in MK-801-treated mice in a dose-dependent manner. Following oral administration of fasudil, brain hydroxyfasudil was detected at concentration above the Ki value for Rho-kinase whilst fasudil was undetectable. MK-801-induced hyperlocomotion was also improved by oral fasudil administration. These results suggest that fasudil has antipsychotic-like effects on the MK-801-treated pharmacological mouse schizophrenia model. There are two isoforms in Rho-kinase, and further investigation is needed to clarify the isoforms involved in the antipsychotic-like effects of fasudil in the MK-801-treated mouse schizophrenia model.
[Display omitted]
•Fasudil and hydroxyfasudil concentrations reached Ki values for Rho-kinase with fasudil (10 mg kg−1, i.p.).•Fasudil improved MK-801-induced deficits in locomotion, social behavior, prepulse inhibition and novel object recognition.•Fasudil may have antipsychotic-like effects comparable to haloperidol and clozapine in schizophrenia.</description><identifier>ISSN: 0014-2999</identifier><identifier>EISSN: 1879-0712</identifier><identifier>DOI: 10.1016/j.ejphar.2022.175207</identifier><language>eng</language><publisher>Elsevier B.V</publisher><subject>Behavioral test ; Fasudil ; MK-801 ; Schizophrenia</subject><ispartof>European journal of pharmacology, 2022-09, Vol.931, p.175207-175207, Article 175207</ispartof><rights>2022 Elsevier B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-626ef95dbe3d989b32cfbf49284b6a481d1eee1c85c3d44c2e708bfa194086503</citedby><cites>FETCH-LOGICAL-c405t-626ef95dbe3d989b32cfbf49284b6a481d1eee1c85c3d44c2e708bfa194086503</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejphar.2022.175207$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids></links><search><creatorcontrib>Takase, Saeko</creatorcontrib><creatorcontrib>Liao, Jingzhu</creatorcontrib><creatorcontrib>Liu, Yue</creatorcontrib><creatorcontrib>Tanaka, Rinako</creatorcontrib><creatorcontrib>Miyagawa, Yasuhiro</creatorcontrib><creatorcontrib>Sawahata, Masahito</creatorcontrib><creatorcontrib>Sobue, Akira</creatorcontrib><creatorcontrib>Mizoguchi, Hiroyuki</creatorcontrib><creatorcontrib>Nagai, Taku</creatorcontrib><creatorcontrib>Kaibuchi, Kozo</creatorcontrib><creatorcontrib>Ozaki, Norio</creatorcontrib><creatorcontrib>Yamada, Kiyofumi</creatorcontrib><title>Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia</title><title>European journal of pharmacology</title><description>Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using genome-wide analysis. ARHGAP10 encodes a RhoGAP superfamily member that is involved in small GTPase signaling. In mice, Arhgap10 gene variations result in RhoA/Rho-kinase pathway activation. We evaluated the pharmacokinetics of fasudil and hydroxyfasudil using liquid chromatography-tandem mass spectrometry in mice. The antipsychotic effects of fasudil on hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits were also investigated in a MK-801-treated pharmacological mouse schizophrenia model. Fasudil and its major metabolite, hydroxyfasudil, were detected in the brain at concentrations above their respective Ki values for Rho-kinase after intraperitoneal injection of 10 mg kg−1 fasudil. Fasudil improved the hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits in MK-801-treated mice in a dose-dependent manner. Following oral administration of fasudil, brain hydroxyfasudil was detected at concentration above the Ki value for Rho-kinase whilst fasudil was undetectable. MK-801-induced hyperlocomotion was also improved by oral fasudil administration. These results suggest that fasudil has antipsychotic-like effects on the MK-801-treated pharmacological mouse schizophrenia model. There are two isoforms in Rho-kinase, and further investigation is needed to clarify the isoforms involved in the antipsychotic-like effects of fasudil in the MK-801-treated mouse schizophrenia model.
[Display omitted]
•Fasudil and hydroxyfasudil concentrations reached Ki values for Rho-kinase with fasudil (10 mg kg−1, i.p.).•Fasudil improved MK-801-induced deficits in locomotion, social behavior, prepulse inhibition and novel object recognition.•Fasudil may have antipsychotic-like effects comparable to haloperidol and clozapine in schizophrenia.</description><subject>Behavioral test</subject><subject>Fasudil</subject><subject>MK-801</subject><subject>Schizophrenia</subject><issn>0014-2999</issn><issn>1879-0712</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1LxDAQxYMouH78Bx569GDXSTZtk4sg4hcIgug5pOnEztptatIV9K-3Sz17moF57w3vx9gZhyUHXl6ul7geWhuXAoRY8qoQUO2xBVeVzqHiYp8tALjMhdb6kB2ltAaAQotiwcJ1P9KQvl0bRnJ5Rx-YoffoxpQFn3mbtg11F5nNXtqQf1BvE2bUt1TTGOLFtE6n3e-NdaEL7-Qy29PGdtkmNNjtMpJr6ScMbcSe7Ak78LZLePo3j9nb3e3rzUP-9Hz_eHP9lDsJxZiXokSvi6bGVaOVrlfC-dpLLZSsSysVbzgicqcKt2qkdAIrULW3XEtQZQGrY3Y-5w4xfG4xjWZDyWHX2R7DNhlRgVSlBiUnqZylLoaUInozxKlB_DYczI6vWZuZr9nxNTPfyXY123Cq8UUYTXKEvcOG4oTPNIH-D_gFviaG8A</recordid><startdate>20220915</startdate><enddate>20220915</enddate><creator>Takase, Saeko</creator><creator>Liao, Jingzhu</creator><creator>Liu, Yue</creator><creator>Tanaka, Rinako</creator><creator>Miyagawa, Yasuhiro</creator><creator>Sawahata, Masahito</creator><creator>Sobue, Akira</creator><creator>Mizoguchi, Hiroyuki</creator><creator>Nagai, Taku</creator><creator>Kaibuchi, Kozo</creator><creator>Ozaki, Norio</creator><creator>Yamada, Kiyofumi</creator><general>Elsevier B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20220915</creationdate><title>Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia</title><author>Takase, Saeko ; Liao, Jingzhu ; Liu, Yue ; Tanaka, Rinako ; Miyagawa, Yasuhiro ; Sawahata, Masahito ; Sobue, Akira ; Mizoguchi, Hiroyuki ; Nagai, Taku ; Kaibuchi, Kozo ; Ozaki, Norio ; Yamada, Kiyofumi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-626ef95dbe3d989b32cfbf49284b6a481d1eee1c85c3d44c2e708bfa194086503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Behavioral test</topic><topic>Fasudil</topic><topic>MK-801</topic><topic>Schizophrenia</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Takase, Saeko</creatorcontrib><creatorcontrib>Liao, Jingzhu</creatorcontrib><creatorcontrib>Liu, Yue</creatorcontrib><creatorcontrib>Tanaka, Rinako</creatorcontrib><creatorcontrib>Miyagawa, Yasuhiro</creatorcontrib><creatorcontrib>Sawahata, Masahito</creatorcontrib><creatorcontrib>Sobue, Akira</creatorcontrib><creatorcontrib>Mizoguchi, Hiroyuki</creatorcontrib><creatorcontrib>Nagai, Taku</creatorcontrib><creatorcontrib>Kaibuchi, Kozo</creatorcontrib><creatorcontrib>Ozaki, Norio</creatorcontrib><creatorcontrib>Yamada, Kiyofumi</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Takase, Saeko</au><au>Liao, Jingzhu</au><au>Liu, Yue</au><au>Tanaka, Rinako</au><au>Miyagawa, Yasuhiro</au><au>Sawahata, Masahito</au><au>Sobue, Akira</au><au>Mizoguchi, Hiroyuki</au><au>Nagai, Taku</au><au>Kaibuchi, Kozo</au><au>Ozaki, Norio</au><au>Yamada, Kiyofumi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia</atitle><jtitle>European journal of pharmacology</jtitle><date>2022-09-15</date><risdate>2022</risdate><volume>931</volume><spage>175207</spage><epage>175207</epage><pages>175207-175207</pages><artnum>175207</artnum><issn>0014-2999</issn><eissn>1879-0712</eissn><abstract>Current antipsychotics used to treat schizophrenia have associated problems, including serious side effects and treatment resistance. We recently identified a significant association of schizophrenia with exonic copy number variations in the Rho GTPase activating protein 10 (ARHGAP10) gene using genome-wide analysis. ARHGAP10 encodes a RhoGAP superfamily member that is involved in small GTPase signaling. In mice, Arhgap10 gene variations result in RhoA/Rho-kinase pathway activation. We evaluated the pharmacokinetics of fasudil and hydroxyfasudil using liquid chromatography-tandem mass spectrometry in mice. The antipsychotic effects of fasudil on hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits were also investigated in a MK-801-treated pharmacological mouse schizophrenia model. Fasudil and its major metabolite, hydroxyfasudil, were detected in the brain at concentrations above their respective Ki values for Rho-kinase after intraperitoneal injection of 10 mg kg−1 fasudil. Fasudil improved the hyperlocomotion, social interaction deficits, prepulse inhibition deficits, and novel object recognition deficits in MK-801-treated mice in a dose-dependent manner. Following oral administration of fasudil, brain hydroxyfasudil was detected at concentration above the Ki value for Rho-kinase whilst fasudil was undetectable. MK-801-induced hyperlocomotion was also improved by oral fasudil administration. These results suggest that fasudil has antipsychotic-like effects on the MK-801-treated pharmacological mouse schizophrenia model. There are two isoforms in Rho-kinase, and further investigation is needed to clarify the isoforms involved in the antipsychotic-like effects of fasudil in the MK-801-treated mouse schizophrenia model.
[Display omitted]
•Fasudil and hydroxyfasudil concentrations reached Ki values for Rho-kinase with fasudil (10 mg kg−1, i.p.).•Fasudil improved MK-801-induced deficits in locomotion, social behavior, prepulse inhibition and novel object recognition.•Fasudil may have antipsychotic-like effects comparable to haloperidol and clozapine in schizophrenia.</abstract><pub>Elsevier B.V</pub><doi>10.1016/j.ejphar.2022.175207</doi><tpages>1</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-2999 |
ispartof | European journal of pharmacology, 2022-09, Vol.931, p.175207-175207, Article 175207 |
issn | 0014-2999 1879-0712 |
language | eng |
recordid | cdi_proquest_miscellaneous_2704869084 |
source | Access via ScienceDirect (Elsevier) |
subjects | Behavioral test Fasudil MK-801 Schizophrenia |
title | Antipsychotic-like effects of fasudil, a Rho-kinase inhibitor, in a pharmacologic animal model of schizophrenia |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T17%3A44%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antipsychotic-like%20effects%20of%20fasudil,%20a%20Rho-kinase%20inhibitor,%20in%20a%20pharmacologic%20animal%20model%20of%20schizophrenia&rft.jtitle=European%20journal%20of%20pharmacology&rft.au=Takase,%20Saeko&rft.date=2022-09-15&rft.volume=931&rft.spage=175207&rft.epage=175207&rft.pages=175207-175207&rft.artnum=175207&rft.issn=0014-2999&rft.eissn=1879-0712&rft_id=info:doi/10.1016/j.ejphar.2022.175207&rft_dat=%3Cproquest_cross%3E2704869084%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2704869084&rft_id=info:pmid/&rft_els_id=S001429992200468X&rfr_iscdi=true |